Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 2/2019

14.11.2018 | Original Article

Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017

verfasst von: Liang En Wee, Mangaikarasi Sundarajoo, Way-Fang Quah, Ahmad Farhati, Jie-ying Huang, Ying-Ying Chua

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Outpatient parenteral antibiotic therapy (OPAT) can facilitate early discharge; however, not all offered OPAT can accept. We assessed factors associated with acceptance of OPAT in a large Asian tertiary hospital cohort. From 2014 to 2017, we reviewed all referrals to Singapore General Hospital’s (SGH) Outpatient Parenteral Antibiotic Therapy (OPAT) service. We compared differences in sociodemographic and clinical factors between patients who opted for OPAT and those who declined, using chi-square test for univariate analysis and logistic regression for multivariate analysis. From 2014 to 2017, a total of 1406 OPAT referrals were made. Of these, 95.9% (1349/1406) were deemed suitable for OPAT. Amongst those suitable, 90.0% (1213/1349) accepted OPAT treatment. On multivariate analysis, being independently ambulant (aOR = 3.46, 95%CI = 2.21–5.37) was independently associated with higher odds of acceptance for OPAT; whereas, patients with peripheral vascular disease had lower odds of accepting OPAT (aOR = 0.32, 95%CI = 0.16–0.62). Lower socioeconomic status (SES) was closely associated with rejection of OPAT, with markers of both individual-level SES (subsidized ward class) and area-level SES (staying in a public rental flat) being independently associated with lower odds of OPAT preference. Distance and travel time were not associated with OPAT acceptance. The top reasons for rejecting OPAT were lack of caregiver (n = 35), mobility issues (n = 24), financial issues (n = 24), and difficulty caring for the line (n = 21). Comorbidities, mobility, and financial issues are important factors to consider when determining suitability for OPAT. More can be done to improve accessibility of OPAT amongst lower-income patients and those staying in lower-SES areas.
Literatur
1.
Zurück zum Zitat Psaltikidis E, Silva E, Bustorff-Silva J, Moretti M, Resende M (2017) Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review. Expert Rev Pharmacoecon Outcomes Res 17(4):355–375CrossRefPubMed Psaltikidis E, Silva E, Bustorff-Silva J, Moretti M, Resende M (2017) Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review. Expert Rev Pharmacoecon Outcomes Res 17(4):355–375CrossRefPubMed
2.
Zurück zum Zitat MacKenzie M, Rae N, Nathwani D (2014) Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents 43(1):7–16CrossRefPubMed MacKenzie M, Rae N, Nathwani D (2014) Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents 43(1):7–16CrossRefPubMed
3.
Zurück zum Zitat Mitchell E, Czoski MC, Meads D, Minton J, Wright J, Twiddy M (2017) Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open 7(4):e013560CrossRefPubMedPubMedCentral Mitchell E, Czoski MC, Meads D, Minton J, Wright J, Twiddy M (2017) Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open 7(4):e013560CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Conant M, Erdman S, Osterholzer D (2014) Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. J Antimicrob Chemother 69(6):1695–1700CrossRefPubMed Conant M, Erdman S, Osterholzer D (2014) Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. J Antimicrob Chemother 69(6):1695–1700CrossRefPubMed
5.
Zurück zum Zitat Heintz B, Halilovic J, Christensen C (2011) Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother 45(11):1329–1337CrossRefPubMed Heintz B, Halilovic J, Christensen C (2011) Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother 45(11):1329–1337CrossRefPubMed
6.
Zurück zum Zitat Fisher D, Michaels J, Hase R, Zhang J, Kataria S, Sim B et al (2017) Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity. J Antimicrob Chemother 72(4):1221–1226PubMed Fisher D, Michaels J, Hase R, Zhang J, Kataria S, Sim B et al (2017) Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity. J Antimicrob Chemother 72(4):1221–1226PubMed
7.
Zurück zum Zitat Fisher D (2017) OPAT in Asia. Int J Antimicrob Agents 50(S2):10–28 Fisher D (2017) OPAT in Asia. Int J Antimicrob Agents 50(S2):10–28
8.
Zurück zum Zitat Chan M, Ooi C, Wong J, Zhong L, Lye D (2017) Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. BMC Infect Dis 17(1):474CrossRefPubMedPubMedCentral Chan M, Ooi C, Wong J, Zhong L, Lye D (2017) Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. BMC Infect Dis 17(1):474CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Fisher D, Kurup A, Lye D, Tambyah P, Sulaiman Z, Poon E et al (2006) Outpatient parenteral antibiotic therapy in Singapore. Int J Antimicrob Agents 28(6):545–560CrossRefPubMed Fisher D, Kurup A, Lye D, Tambyah P, Sulaiman Z, Poon E et al (2006) Outpatient parenteral antibiotic therapy in Singapore. Int J Antimicrob Agents 28(6):545–560CrossRefPubMed
10.
Zurück zum Zitat Yong C, Fisher D, Sklar G, Li S (2009) A cost analysis of outpatient parenteral antibiotic therapy (OPAT): an Asian perspective. Int J Antimicrob Agents 33(1):46–51CrossRefPubMed Yong C, Fisher D, Sklar G, Li S (2009) A cost analysis of outpatient parenteral antibiotic therapy (OPAT): an Asian perspective. Int J Antimicrob Agents 33(1):46–51CrossRefPubMed
11.
Zurück zum Zitat Trad M, Zhong L, Llorin R, Tan S, Chan M, Archuleta S et al (2017) Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections. J Chemother 29(1):25–29CrossRefPubMed Trad M, Zhong L, Llorin R, Tan S, Chan M, Archuleta S et al (2017) Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections. J Chemother 29(1):25–29CrossRefPubMed
12.
Zurück zum Zitat Ingram P, Sulaiman Z, Chua A, Fisher D (2007) Comment on: outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 61(1):226–227CrossRefPubMed Ingram P, Sulaiman Z, Chua A, Fisher D (2007) Comment on: outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 61(1):226–227CrossRefPubMed
13.
Zurück zum Zitat Seetoh T, Lye D, Cook A, Archuleta S, Chan M, Sulaiman Z et al (2013) An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 41(6):569–573CrossRefPubMed Seetoh T, Lye D, Cook A, Archuleta S, Chan M, Sulaiman Z et al (2013) An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 41(6):569–573CrossRefPubMed
14.
Zurück zum Zitat Matthews P, Conlon C, Berendt A, Kayley J, Jefferies L, Atkins B et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60(2):356–362CrossRefPubMed Matthews P, Conlon C, Berendt A, Kayley J, Jefferies L, Atkins B et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60(2):356–362CrossRefPubMed
15.
Zurück zum Zitat Lim M (2005) Transforming Singapore health care: public-private partnership. Ann Acad Med Singap 34(7):461–467PubMed Lim M (2005) Transforming Singapore health care: public-private partnership. Ann Acad Med Singap 34(7):461–467PubMed
16.
Zurück zum Zitat von Eiff W, Massoro T, Voo Y, Ziegenbein R (2002) Medical savings accounts: a core feature of Singapore's health care system. Eur J Health Econ 3(3):188–195CrossRef von Eiff W, Massoro T, Voo Y, Ziegenbein R (2002) Medical savings accounts: a core feature of Singapore's health care system. Eur J Health Econ 3(3):188–195CrossRef
18.
Zurück zum Zitat Chan C, Lee K, Low L (2018) A systematic review of health status, health seeking behaviour and healthcare utilisation of low socioeconomic status populations in urban Singapore. Int J Equity Health 17(1):39CrossRefPubMedPubMedCentral Chan C, Lee K, Low L (2018) A systematic review of health status, health seeking behaviour and healthcare utilisation of low socioeconomic status populations in urban Singapore. Int J Equity Health 17(1):39CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ingram PR, Sulaiman Z, Chua A, Fisher DA (2008) Comment on: Outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 61(1):226–227CrossRefPubMed Ingram PR, Sulaiman Z, Chua A, Fisher DA (2008) Comment on: Outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 61(1):226–227CrossRefPubMed
21.
Zurück zum Zitat Gilchrist M, Franklin B, Patel J (2008) An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 62(1):177–183CrossRefPubMed Gilchrist M, Franklin B, Patel J (2008) An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 62(1):177–183CrossRefPubMed
22.
Zurück zum Zitat Nolet B (1998) Patient selection in outpatient parenteral antimicrobial therapy. Infect Dis Clin N Am 12(4):835–847CrossRef Nolet B (1998) Patient selection in outpatient parenteral antimicrobial therapy. Infect Dis Clin N Am 12(4):835–847CrossRef
23.
Zurück zum Zitat Hodgson K, Huynh J, Ibrahim L, Sacks B, Golshevsky D, Layley M et al (2016) The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Arch Dis Child 101(10):886–893CrossRefPubMed Hodgson K, Huynh J, Ibrahim L, Sacks B, Golshevsky D, Layley M et al (2016) The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Arch Dis Child 101(10):886–893CrossRefPubMed
24.
Zurück zum Zitat Subedi S, Looke D, McDougall D, Sehu M, Playford E (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 30:161–165CrossRefPubMed Subedi S, Looke D, McDougall D, Sehu M, Playford E (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 30:161–165CrossRefPubMed
25.
Zurück zum Zitat Mirón-Rubio M, González-Ramallo V, Estrada-Cuxart O, Sanroma-Mendizábal P, Segado-Soriano A, Mujal-Martínez A et al (2016) Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish outpatient parenteral antimicrobial therapy registry. Future Microbiol 11(3):375–390CrossRefPubMed Mirón-Rubio M, González-Ramallo V, Estrada-Cuxart O, Sanroma-Mendizábal P, Segado-Soriano A, Mujal-Martínez A et al (2016) Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish outpatient parenteral antimicrobial therapy registry. Future Microbiol 11(3):375–390CrossRefPubMed
26.
Zurück zum Zitat Low L, Vasanwala F, Ng L, Chen C, Lee K, Tan S (2015) Effectiveness of a transitional home care program in reducing acute hospital utilization: a quasi-experimental study. BMC Health Serv Res 15(100) Low L, Vasanwala F, Ng L, Chen C, Lee K, Tan S (2015) Effectiveness of a transitional home care program in reducing acute hospital utilization: a quasi-experimental study. BMC Health Serv Res 15(100)
27.
Zurück zum Zitat Low L, Tan S, Ng M, Tay W, Ng L, Balasubramaniam K et al (2017) Applying the integrated practice unit concept to a modified virtual ward model of care for patients at highest risk of readmission: a randomized controlled trial. PLoS One 12(1):e0168757CrossRefPubMedPubMedCentral Low L, Tan S, Ng M, Tay W, Ng L, Balasubramaniam K et al (2017) Applying the integrated practice unit concept to a modified virtual ward model of care for patients at highest risk of readmission: a randomized controlled trial. PLoS One 12(1):e0168757CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Wee L, Koh G, Yeo W, Chin R, Wong J, Seow B (2013) Screening for cardiovascular disease risk factors in an urban low-income setting at baseline and post intervention: a prospective intervention study. Eur J Prev Cardiol 20(1):176–188CrossRefPubMed Wee L, Koh G, Yeo W, Chin R, Wong J, Seow B (2013) Screening for cardiovascular disease risk factors in an urban low-income setting at baseline and post intervention: a prospective intervention study. Eur J Prev Cardiol 20(1):176–188CrossRefPubMed
31.
Zurück zum Zitat Wee L, Koh G, Chin R, Yeo W, Seow B, Chua D (2012) Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention. Prev Med 55(1):61–67CrossRefPubMed Wee L, Koh G, Chin R, Yeo W, Seow B, Chua D (2012) Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention. Prev Med 55(1):61–67CrossRefPubMed
34.
Zurück zum Zitat Ministry of Health S. Medisave uses and withdrawa. 2017 Ministry of Health S. Medisave uses and withdrawa. 2017
35.
Zurück zum Zitat Lim A. New Flexi-Medisave scheme: what it can and cannot be used for. Straits Times. 2015 Jan 12th 2015 Lim A. New Flexi-Medisave scheme: what it can and cannot be used for. Straits Times. 2015 Jan 12th 2015
36.
Zurück zum Zitat Nolet B (2010) Update and overview of outpatient parenteral antimicrobial therapy regulations and reimbursement. Clinical Infect Dis 51(S2):S216–S219CrossRef Nolet B (2010) Update and overview of outpatient parenteral antimicrobial therapy regulations and reimbursement. Clinical Infect Dis 51(S2):S216–S219CrossRef
37.
Zurück zum Zitat Marra C, Frighetto L, Goodfellow A, Wai A, Chase M, Nicol R et al (2005) Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res 7(5):43CrossRef Marra C, Frighetto L, Goodfellow A, Wai A, Chase M, Nicol R et al (2005) Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res 7(5):43CrossRef
38.
Zurück zum Zitat Joynt Maddox K, Orav E, Zheng J, Epstein A (2018) Evaluation of Medicare’s bundled payments initiative for medical conditions. N Engl J Med 379(3):260–269CrossRefPubMed Joynt Maddox K, Orav E, Zheng J, Epstein A (2018) Evaluation of Medicare’s bundled payments initiative for medical conditions. N Engl J Med 379(3):260–269CrossRefPubMed
39.
Zurück zum Zitat Madaline T, Nori P, Mowrey W, Zukowski E, Gohil S, Sarwar U et al (2017) Bundle in the Bronx: impact of a transition-of-care outpatient parenteral antibiotic therapy bundle on all-cause 30-day hospital readmissions. Open Forum Infect Dis 4(2) ofx097 Madaline T, Nori P, Mowrey W, Zukowski E, Gohil S, Sarwar U et al (2017) Bundle in the Bronx: impact of a transition-of-care outpatient parenteral antibiotic therapy bundle on all-cause 30-day hospital readmissions. Open Forum Infect Dis 4(2) ofx097
Metadaten
Titel
Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017
verfasst von
Liang En Wee
Mangaikarasi Sundarajoo
Way-Fang Quah
Ahmad Farhati
Jie-ying Huang
Ying-Ying Chua
Publikationsdatum
14.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 2/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3424-2

Weitere Artikel der Ausgabe 2/2019

European Journal of Clinical Microbiology & Infectious Diseases 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.